BackHealth Catalyst Overview

Health Catalyst Receivables

Track Health Catalyst's receivables ($59M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$59.15M
7.65% YoYΔ $-4.90M vs prior year quarter

Peer average

Loading

Health Catalyst Receivables History

Loading

Health Catalyst vs. peers: Receivables Comparison

Loading

Health Catalyst Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Health Catalyst (HCAT) FAQ

As of the most recent data (March 2026), HCAT shows a receivables of $59M. That compares with $64M in the prior-year period — down 7.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HCAT's receivables is now $59M (was $64M) — a 7.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Health Catalyst is outperforming or lagging.

Tracking HCAT's receivables over time shows whether Health Catalyst is scaling, shrinking, or reshaping that part of the business. The current reading is $59M That compares with $64M in the prior-year period — down 7.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Health Catalyst's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $59M) with ownership activity and broader fundamentals.

Health Catalyst's receivables is $59M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.